| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:466080386:1746 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:466080386:1746?format=raw |
LEADER: 01746cam a2200421 a 4500
001 3919078
005 20221027001702.0
008 850212s1984 nyua b 101 0 eng
010 $a 83042855
020 $a0890043418
035 $a(OCoLC)10322613
035 $a(OCoLC)ocm10322613
035 $a(CStRLIN)NYCM85-B511
035 $9ADH1470HS
035 $a(NNC)3919078
035 $a3919078
040 $dCStRLIN
050 10 $aRC632.H88$bT74 1984
060 0 $aWD 205.5.L5 T784 1983
082 0 $a616.3/99$219
245 00 $aTreatment of hyperlipoproteinemia /$cLars A. Carlson, Anders G. Olsson, editors.
260 $aNew York :$bRaven Press,$c1984.
300 $axviii, 284 pages :$billustrations ;$c27 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $a"With the sponsorship of the European Atherosclerosis Group"--Pref.
504 $aIncludes bibliographical references and index.
650 0 $aHyperlipoproteinemia$xTreatment.
650 0 $aAtherosclerosis$xPrevention.
650 2 $aHyperlipoproteinemias$xtherapy.$0https://id.nlm.nih.gov/mesh/D006951Q000628
650 2 $aArteriosclerosis$xtherapy.$0https://id.nlm.nih.gov/mesh/D001161Q000628
650 2 $aArteriosclerosis$xetiology.$0https://id.nlm.nih.gov/mesh/D001161Q000209
650 2 $aHyperlipoproteinemias$xcomplications.$0https://id.nlm.nih.gov/mesh/D006951Q000150
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aCarlson, Lars A.$0http://id.loc.gov/authorities/names/n81128250
700 1 $aOlsson, Anders G.$0http://id.loc.gov/authorities/names/n82230538
710 2 $aEuropean Atherosclerosis Group.$0http://id.loc.gov/authorities/names/n80090056
852 00 $boff,hsl$hRC632.H88$iT71 1984